Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells.

Authors:

William W Au
William W Au

30 August 2008

journal article

Vol. 28, 2181-7
PMID:18751393
PMCID:PMC4477542

Abstract

We have reported that a gene therapy approach, using a dominant-negative estrogen receptor blocker (DN) gene, can cause cell death in cervical cancer cells in vitro. We investigated the mechanisms for enhanced cell killing when DN was combined with cisplatin (CP) and paclitaxel (TX). Cells were transduced with DN at 24 h and/or treated with drugs at 48 h, and harvested at 48 and 72 h after transduction. Effects were determined using the MTT cytotoxic, and TUNEL and caspase-3 activity apoptotic assays. Each agent induced cytotoxic and apoptotic effects, and activated caspase-3. In the combined treatments, significant synergistic effects were observed based on the MTT and TUNEL assays, but with antagonistic caspase-3 activation effect. The enhanced cell killing effect was mediated by the initiation of new and multiple mechanisms, particularly via caspase-independent pathways.

Keywords

This publication has 30 references indexed in Scilit:

Nuclear translocation of apoptosis inducing factor is associated with cisplatin induced apoptosis in LNCaP prostate cancer cells
Cancer Letters, 2007
Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines
Cancer Biology & Therapy, 2007
Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL
Molecular and Cellular Biochemistry, 2007
Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers
Cancer Research, 2007
Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets, 2007
Recent advances in understanding the cell death pathways activated by anticancer therapy
Cancer, 2005
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines
Cancer Chemotherapy and Pharmacology, 2004
Cervical cancer and use of hormonal contraceptives: a systematic review
The Lancet, 2003
A Multistep Model for Paclitaxel-Induced Apoptosis in Human Breast Cancer Cell Lines
Experimental Cell Research, 2001
Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
1999